Nasal high flow oxygen therapy offers another option for patients requiring non-invasive respiratory support. Nasal high flow oxygen therapy allows delivery of a prescribed FiO2 with reduced air entrainment and dilution. This therapy may be beneficial in that nasal interfaces may be better tolerated and children receive the benefits of humidification and likely also receive a low level positive airway pressure.

Market Analysis and Insights: Global High Flow Oxygen Cannula Market
The global High Flow Oxygen Cannula market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global High Flow Oxygen Cannula Scope and Market Size
The global High Flow Oxygen Cannula market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global High Flow Oxygen Cannula market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Pediatric
Adult

Segment by Application
Home Care
Hospitals
Ambulatory Surgical Centers

The High Flow Oxygen Cannula market is analysed and market size information is provided by regions (countries). Segment by Application, the High Flow Oxygen Cannula market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Fisher & Paykel Healthcare
Vapotherm
ResMed
Teleflex
Salter Labs
Flexicare
Great Group Medical
Smiths Medical
medin Medical Innovations
Armstrong Medical